Simoctocog Alfa

4 trials 4 recruiting BHaematology

Filter these 4 trials by condition, phase, country and more.

Open in Search →

4 Registered trials

4 Recruiting

0 Completed trials

4 Sponsors

15 Countries

Phase III

Phase IV

Phase III: 1 Phase IV: 3

Sponsors using this IMP

Octapharma AG 2 Emory University 1 F. Hoffmann-La Roche AG 1 HZRM Haemophilie-Zentrum Rhein Main GmbH 1

All trials

4 total

A Clinical Study to Evaluate the Effects of NXT007 Compared to Factor VIII Prophylaxis in People With Hemophilia A Recruiting

2025-522434-32-00 Phase III 9 countries F. Hoffmann-La Roche AG
Nuwiq Dosing and outcomes In the ManagEment of women/girls with haemophilia A Needing FVIII treatment for Surgery – an International, Open-l… Recruiting

2022-502061-17-00 Phase IV 6 countries Octapharma AG
Nuwiq for Perioperative management Of patients With haemophilia A on Emicizumab Regular prophylaxis study (NuPOWER) Recruiting

2022-502060-21-00 Phase IV 6 countries Octapharma AG
An international investigator initiated trial to capture different approaches in the treatment of Haemophilia A Patients With FVIII Inhibito… Recruiting

2024-516741-39-00 Phase IV 7 countries Emory University; HZRM Haemophilie-Zentrum Rhein Main GmbH

Showing 1–4 of 4 trials

← All drugs A–Z